On 19 Nov 2025, Sequent Scientific’s stock touched an intraday high of Rs.260.3, representing a notable advance from its 52-week low of Rs.111. The stock opened with a gap up of 2.58%, signalling positive investor sentiment at the start of the trading session. Despite a slight retreat of 0.73% by the day’s close, the stock remains firmly above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, underscoring its robust technical positioning.
In comparison, the Sensex opened flat and traded marginally higher by 0.04% at 84,710.91 points, remaining 0.68% shy of its own 52-week high of 85,290.06. The mid-cap segment led the market with a gain of 0.14%, while Sequent Scientific’s sector, Pharmaceuticals & Biotechnology, showed a mixed performance with the stock slightly underperforming the sector by 0.36% on the day.
Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!
- Current monthly selection
- Single best opportunity
- Elite universe pick
Sequent Scientific’s year-on-year performance stands out with a gain of 25.98%, significantly outpacing the Sensex’s 9.20% over the same period. This differential highlights the stock’s relative strength within the broader market context. The company’s market capitalisation grade remains at 3, reflecting its mid-tier valuation status within the Pharmaceuticals & Biotechnology sector.
The stock’s momentum has been supported by a series of positive technical signals. Trading above all major moving averages suggests sustained buying interest and a favourable trend. However, the stock experienced a minor pullback after two consecutive days of gains, indicating some profit-taking or consolidation at these elevated levels.
Sequent Scientific’s Mojo Score currently stands at 57.0, with a Mojo Grade of Hold as of 2 September 2025, following an adjustment in its evaluation from a previous Sell grade. This revision reflects changes in the company’s financial and market metrics, as well as recent price action, including the recent 52-week high trigger on 19 November 2025.
Is Sequent Scientific your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- Better alternatives suggested
- Cross-sector comparison
- Portfolio optimization tool
Market participants will note that Sequent Scientific’s stock price has demonstrated resilience despite a day’s slight underperformance relative to its sector. The stock’s ability to maintain levels above its key moving averages is a technical indicator often associated with sustained upward momentum. The gap-up opening today further emphasises the stock’s positive sentiment at the market open, even as it faced some intraday volatility.
Overall, Sequent Scientific’s achievement of a new 52-week high at Rs.260.3 is a noteworthy event within the Pharmaceuticals & Biotechnology sector. The stock’s performance over the past year, combined with its current technical positioning, provides a comprehensive picture of its market standing as of late 2025.
Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
